Stem cell injection aims to calm kidney transplant rejection

NCT ID NCT05456243

First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 23 times

Summary

This early-stage study tests whether injecting donor stem cells directly into the artery of a transplanted kidney is safe and can reduce inflammation from rejection. It involves 12 adult kidney transplant recipients who have signs of rejection on biopsy. The goal is to see if this experimental approach can help control rejection without causing serious side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.